Drug · DIN 02230454
BROMOCRIPTINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 17, 2012; first marketed January 8, 1997.
- Drug Identification Number (DIN)
- 02230454
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Bromocriptine N04BC01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 7, 2012: NOC 13643New Drug Submission (NDS) · Manufacturer and product name change
- January 8, 1997: NOC 3320Supplement to a New Drug Submission (SNDS) · New strength and dosage form
Other DINs named BROMOCRIPTINE
- DIN 02087324 · Marketed
- DIN 02238192 · Cancelled Post Market
- DIN 02238193 · Cancelled Post Market